\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ palpable\\ mass\\ on\\ clinical\\ breast\\ exam\\.\ \(0\)\
\-\ lumpectomy\\ and\\ sentinel\\ node\\ biopsy\\.\\ the\\ sentinel\\ node\\ was\\ negative\\.\ \(0\)\
\-\ enhancing\\ spiculated\\ mass\\ noted\\ in\\ the\\ upper\\ outer\\ quadrant\\ of\\ the\\ right\\ breast\\.\ \(0\)\
\-\ infiltrating\\ ductal\\ carcinoma\\ dx\\.\\ by\\ mri\ \(0\)\
\-\ 48\\ y\\.o\\.\\ female\\ presents\\ for\\ screening\\ mammogram\\.\\ \\ pt\\.\\ with\\ prior\\ stereotactic\\ biopsy\\ of\\ the\\ right\\ breast\\ for\\ calcifications\\ 18\\ mo\\.\\ prior\\ found\\ to\\ have\\ atypical\\ ductal\\ hyperplasia\\.\\ \\ breast\\ mri\\ was\\ recommended\\ as\\ patients\\ breast\\ were\\ heterogenously\\ dense\\ and\\ patient\\ was\\ at\\ increased\\ risk\\ of\\ malignancy\\ with\\ hx\\.\\ of\\ adh\\ and\\ positive\\ family\\ history\\ \\(maternal\\ aunt\\ with\\ carcinoma\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.44568504928323993\ \(0\)\
\-\ sentinel\\:\\ 0\\.30885970823061243\ \(0\)\
\-\ ductal\\:\\ 0\\.21604039121849294\ \(0\)\
\-\ node\\:\\ 0\\.21101090117567067\ \(0\)\
\-\ adh\\:\\ 0\\.17658571706047824\ \(0\)\
\-\ biopsy\\:\\ 0\\.1720858208648515\ \(0\)\
\-\ heterogenously\\:\\ 0\\.15774694514735782\ \(0\)\
\-\ aunt\\:\\ 0\\.15294523117662495\ \(0\)\
\-\ carcinoma\\:\\ 0\\.1468462139287635\ \(0\)\
\-\ stereotactic\\:\\ 0\\.145704854164462\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.14195303122372724\ \(0\)\
\-\ dx\\:\\ 0\\.1380297452436159\ \(0\)\
\-\ prior\\:\\ 0\\.1373569425401083\ \(0\)\
\-\ mo\\:\\ 0\\.1366409732321839\ \(0\)\
\-\ maternal\\:\\ 0\\.13410645926350456\ \(0\)\
\-\ spiculated\\:\\ 0\\.1329430138930102\ \(0\)\
\-\ was\\:\\ 0\\.12833808059700008\ \(0\)\
\-\ mri\\:\\ 0\\.12601723899326445\ \(0\)\
\-\ infiltrating\\:\\ 0\\.1204209365208444\ \(0\)\
\-\ outer\\:\\ 0\\.11802752796000114\ \(0\)\
\-\ mammogram\\:\\ 0\\.11719444982302031\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.11190794318724542\ \(0\)\
\-\ hx\\:\\ 0\\.1116959365700002\ \(0\)\
\-\ dense\\:\\ 0\\.10819877337759777\ \(0\)\
\-\ 48\\:\\ 0\\.106311481056895\ \(0\)\
\-\ atypical\\:\\ 0\\.10070373661710248\ \(0\)\
\-\ screening\\:\\ 0\\.09971420606872433\ \(0\)\
\-\ the\\:\\ 0\\.09797176429479154\ \(0\)\
\-\ recommended\\:\\ 0\\.0976413053333832\ \(0\)\
\-\ family\\:\\ 0\\.09657051240996117\ \(0\)\
\-\ of\\:\\ 0\\.09608600994501063\ \(0\)\
\-\ mass\\:\\ 0\\.09377394197123262\ \(0\)\
\-\ 18\\:\\ 0\\.09301597347796288\ \(0\)\
\-\ malignancy\\:\\ 0\\.09189451543315673\ \(0\)\
\-\ calcifications\\:\\ 0\\.089585328105415\ \(0\)\
\-\ pt\\:\\ 0\\.08833859289739082\ \(0\)\
\-\ risk\\:\\ 0\\.08770668296087361\ \(0\)\
\-\ palpable\\:\\ 0\\.08623590273581737\ \(0\)\
\-\ quadrant\\:\\ 0\\.08597896239847458\ \(0\)\
\-\ right\\:\\ 0\\.08139297000690292\ \(0\)\
\-\ positive\\:\\ 0\\.08088551071752442\ \(0\)\
\-\ found\\:\\ 0\\.07942441812300086\ \(0\)\
\-\ clinical\\:\\ 0\\.07779276119121187\ \(0\)\
\-\ enhancing\\:\\ 0\\.07689513661576686\ \(0\)\
\-\ and\\:\\ 0\\.07609394477082905\ \(0\)\
\-\ negative\\:\\ 0\\.0759932771095508\ \(0\)\
\-\ for\\:\\ 0\\.07440876566864603\ \(0\)\
\-\ with\\:\\ 0\\.07210756598479255\ \(0\)\
\-\ patients\\:\\ 0\\.0690532168007548\ \(0\)\
\-\ increased\\:\\ 0\\.06637700613721265\ \(0\)\
\-\ upper\\:\\ 0\\.06559534617902892\ \(0\)\
\-\ noted\\:\\ 0\\.06508152023197336\ \(0\)\
\-\ were\\:\\ 0\\.06327373781021928\ \(0\)\
\-\ exam\\:\\ 0\\.06179207905607169\ \(0\)\
\-\ have\\:\\ 0\\.061320028229027844\ \(0\)\
\-\ female\\:\\ 0\\.05923221802942406\ \(0\)\
\-\ presents\\:\\ 0\\.05904876851606936\ \(0\)\
\-\ by\\:\\ 0\\.05212648882509479\ \(0\)\
\-\ as\\:\\ 0\\.04931276622204635\ \(0\)\
\-\ history\\:\\ 0\\.04689735385558278\ \(0\)\
\-\ at\\:\\ 0\\.046363979611834485\ \(0\)\
\-\ patient\\:\\ 0\\.03992419808368042\ \(0\)\
\-\ no\\:\\ 0\\.03991668857476177\ \(0\)\
\-\ on\\:\\ 0\\.037072407581090934\ \(0\)\
\-\ to\\:\\ 0\\.030687093835728128\ \(0\)\
\-\ in\\:\\ 0\\.03053605202342383\ \(0\)\
